Clinical Trials · NCT02070198

Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF

Name: Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 4Gonadorelin

Phase: Phase 4
Recruitment status: Unknown
Sponsor: Bioroma
Enrollment: 120
Start date: Dec 2013
Locations: 1 site, Italy
Primary endpoint: Clinical pregnancy rate

View Gonadorelin compound reference